Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Acetaminophen for osteoarthritis.

T E Towheed1, L Maxwell, M G Judd

  • 1Queen's University, Medicine and of Community Health and Epidemiology, Etherington Hall-Room 2066, Kingston, Ontario, Canada, K7L 3N6. tt5@post.queensu.ca

The Cochrane Database of Systematic Reviews
|January 27, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Ex vivo drug screening and clustering of bladder cancers for pre-clinical treatment prediction.

Communications medicine·2026
Same author

Standardizing health outcomes for people with rheumatoid arthritis receiving disease modifying drug therapy: A rapid review of patient-decision aids and preference studies to inform the development of OMERACT Health Outcome Descriptors.

Seminars in arthritis and rheumatism·2025
Same author

Assessing domain match and feasibility of candidate instruments matching with OMERACT endorsed domains to measure flare in knee and hip osteoarthritis.

Seminars in arthritis and rheumatism·2024
Same author

Early COVID-19 pandemic modeling: Three compartmental model case studies from Texas, USA.

Computing in science & engineering·2022
Same author

A Short Report Examining the Introduction of Routine Use of Patient-Reported Outcome Measures in a Mixed Oncology Population.

Clinical oncology (Royal College of Radiologists (Great Britain))·2021
Same author

<i>trips4health</i>: Protocol of a single-blinded randomised controlled trial incentivising adults to use public transport for physical activity gain.

Contemporary clinical trials communications·2020
Same journal

Interventions to prevent or cease electronic cigarette use in children and adolescents.

The Cochrane database of systematic reviews·2026
Same journal

Drugs to improve anaemia, quality of life, and physical function in people with myelodysplastic syndromes (MDS).

The Cochrane database of systematic reviews·2026
Same journal

Interventions for smoking cessation in inpatient psychiatry settings.

The Cochrane database of systematic reviews·2026
Same journal

Mechanical thromboprophylaxis for preventing intradialytic hypotension in people undergoing maintenance haemodialysis.

The Cochrane database of systematic reviews·2026
Same journal

Prognostic models for predicting intensive care unit admission or mortality in critically ill adults not yet been admitted to the intensive care unit.

The Cochrane database of systematic reviews·2026
Same journal

Views and experiences of weight management for people living with mobility‑limiting conditions, intellectual disabilities or severe mental illness: a qualitative evidence synthesis.

The Cochrane database of systematic reviews·2026
See all related articles

Non-steroidal anti-inflammatory drugs (NSAIDs) are more effective than acetaminophen for osteoarthritis pain relief, though both have similar safety profiles. NSAIDs offer greater benefits for moderate-to-severe pain, but trial durations were short.

Area of Science:

  • Rheumatology
  • Pharmacology
  • Clinical Research

Background:

  • Osteoarthritis (OA) is the most prevalent form of arthritis, necessitating clear treatment guidelines.
  • Current guidelines and expert opinions differ on whether acetaminophen (paracetamol) or non-steroidal anti-inflammatory drugs (NSAIDs) should be the primary pharmacologic treatment for OA.
  • Comparative safety data between acetaminophen and NSAIDs is crucial for informed clinical decisions.

Purpose of the Study:

  • To evaluate the efficacy and safety of acetaminophen compared to placebo.
  • To assess the efficacy and safety of acetaminophen in comparison to various NSAIDs (e.g., ibuprofen, diclofenac, celecoxib, naproxen).
  • To provide evidence-based recommendations for first-line pharmacologic therapy in osteoarthritis management.

Main Methods:

Related Experiment Videos

  • Systematic review and meta-analysis of published randomized controlled trials (RCTs).
  • Searched major databases (MEDLINE, EMBASE, CENTRAL) up to July 2005 for relevant RCTs.
  • Included RCTs focused on acetaminophen efficacy and safety in OA patients, analyzing pain, physical function, and global assessments.

Main Results:

  • Fifteen RCTs involving 5986 participants were analyzed.
  • Acetaminophen showed a statistically significant but clinically questionable improvement in pain compared to placebo (SMD -0.13).
  • NSAIDs demonstrated superior efficacy over acetaminophen for pain reduction, functional status, and global assessments in OA. Safety profiles were similar, though traditional NSAIDs had a higher risk of gastrointestinal events.

Conclusions:

  • NSAIDs are more effective than acetaminophen for managing knee and hip pain in osteoarthritis.
  • The modest treatment effect and short trial durations (median 6 weeks) warrant careful consideration in treatment decisions.
  • For moderate-to-severe OA pain, NSAIDs appear to be the more effective therapeutic option.